Mumbai, 2nd December 2021: As part of a larger initiative of driving digital transformation across all facets of its home loan business, LIC HFL has announced the inauguration of …

Weather Forecast

New York
overcast clouds
53%
1.3km/h
90%
8°C
11°
4°
7°
Tue
4°
Wed
2°
Thu
3°
Fri
6°
Sat
Top Selling Multipurpose WP Theme

Get the best of Soledad Modern News delivered to your inbox

Subscribe my Newsletter for new blog posts, tips & new photos. Let's stay updated!

banner
banner
Home Health updates $ 1.22 Billion Growth Expected in Peripheral Vascular Stents Market | COVID-19 Impact Analysis in Q1 2021 | North America to Notice Maximum Growth | Technavio

$ 1.22 Billion Growth Expected in Peripheral Vascular Stents Market | COVID-19 Impact Analysis in Q1 2021 | North America to Notice Maximum Growth | Technavio

by Prittle Prattle Bureau

NEW YORK, May 12, 2021 The global peripheral vascular stents market by product (Self-expanding, balloon-expanding, and drug-eluting), geography (North America, Europe, Asia, and ROW), and end-user (hospitals, ASCs, and cath labs) has been added to Technavio’s offering. The global peripheral vascular stents market is expected to grow by USD 1.22 billion, at a CAGR of almost 8% during 2020-2024.

The market witnessed a certain decline in the production volume of peripheral vascular stents in 2020 due to the rapid spread of COVID-19. The pandemic hampered the production capacity of vendors, which impeded market growth. However, the increasing adoption of MI angioplasty procedures and the expansion of the global geriatric population are expected to foster market growth during the forecast period.

The market is expected to be driven by factors such as the rising prevalence of PAD and the introduction of bio-absorbable stents.

Peripheral Vascular Stents Market: Opportunities

Countries such as Germany, Italy, the UK, and France are witnessing an increase in the number of the older population. Additionally, healthcare providers and caregivers in these countries are exhibiting high demand for healthcare products that are highly efficient, safe, and cost-effective. This is expected to create a significant demand for peripheral vascular stents, especially in the European market over the coming years, thereby creating new growth opportunities for players in the market.

Peripheral Vascular Stents Market: Segmentation by Product

Based on the segmentation by product, the market generated maximum revenue in the self-expanding peripheral vascular stents segment in 2019. The segment is driven by the increasing prevalence of PAD and the rising usage of these stents in peripheral interventions. Also, self-expanding peripheral vascular stents have better fatigue life compared to types of peripheral vascular stents, which is contributing to the growth of the segment.

Peripheral Vascular Stents Market: Segmentation by Geography

North America held the largest market share in 2019 and the market growth in the region is expected to be slower compared to the growth of the market in Asia and Europe. The growth of the market in North America can be attributed to the increasing number of product launches by vendors operating in the region. In addition, the growing awareness about PAD among people is contributing to the growth of the peripheral vascular stents market in North America.

Develop strategies to make the most of future growth opportunities

Grab an Exclusive Report Now!

Peripheral Vascular Stents Market: Major Vendors

Abbott Laboratories

The company offers products for rhythm management, electrophysiology, heart failure, vascular, structural heart, and neuromodulation. Supera peripheral stent system is the key product offered by the company. It is indicated for the superficial femoral artery and the popliteal artery.

B. Braun Melsungen AG

The company offers VascuFlex Peripheral Stent. It is a highly flexible self-expanding stent for the treatment of arterial vascular occlusions of the iliac artery, the femoral artery, and the popliteal artery.

Becton, Dickinson and Co.

The company offers a range of medication delivery solutions, medication management solutions, diabetes care, and pharmaceutical systems. LIFESTENT 5F Vascular Stent System is the key product offered by the company. This stent system is indicated for the treatment of PAD.

Boston Scientific Corp.

The company offers a variety of implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, less-invasive medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart, and devices to treat various neurological movement disorders and manage chronic pain. Innova Vascular Self-Expanding Stent System is the key product offered by the company. This self-expanding stent is indicated for the treatment of PAD.

Cardinal Health Inc.

The company offers PALMAZ GENESIS Peripheral Stent, S.M.A.R.T Flex, and PALMAZ Blue. These products are specially designed to offer increased radiopacity, low profiles, and superior flexibility and deliverability.

Request for a complete report to know the strategy adopted by Vendors during the COVID-19 recovery phase

Related Reports on Peripheral Vascular Stents Market:

Global Bioabsorbable Stents Market – Know about the latest consumer trends, major vendor offerings, and factors impacting the growth of the bioabsorbable stents market.

Download Exclusive Free Sample Report

Global Biliary Stents Market – Global biliary stents market is expected to witness maximum growth in North America during 2020-2024. Explore information on the production, sustainability, and prospects of several leading companies.

Download Exclusive Free Sample Report

Global Neuroendovascular Coils Market – Analyze the impact of the COVID-19 pandemic on the neuroendovascular coils market, adopt better marketing tactics, and prepare for what’s next.

Download Exclusive Free Sample Report

Global Embolization Coil Market – The global embolization coil market is expected to benefit from the growing popularity of minimally invasive surgeries, the presence of established healthcare infrastructure, and the availability of highly skilled professionals.

Download Exclusive Free Sample Report

Global Endovenous Ablation Devices Market – Global endovenous ablation devices market is segmented by product (EVLT devices, RFA devices, and NTNT devices) and geography (North America, Europe, Asia, and ROW).

Download Exclusive Free Sample Report

Executive Summary
Market Landscape
  • Market ecosystem
  • Market characteristics
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 – 2024
Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Product
  • Market segments
  • Comparison by Product
  • Self-expanding peripheral vascular stents – Market size and forecast 2019-2024
  • Balloon-expanding peripheral vascular stents – Market size and forecast 2019-2024
  • Drug-eluting peripheral vascular stents – Market size and forecast 2019-2024
  • Market opportunity by Product
Market Segmentation by End-user
  • Hospitals
  • ASCs
  • Cath labs
Customer landscape
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America – Market size and forecast 2019-2024
  • Europe – Market size and forecast 2019-2024
  • Asia – Market size and forecast 2019-2024
  • ROW – Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Vendor landscape
  • Landscape disruption
  • Competitive Scenario
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Boston Scientific Corp.
  • Cardinal Health Inc.
  • Cook Medical LLC
  • Medtronic Plc
  • MicroPort Scientific Corp.
  • Terumo Corp.
  • W. L. Gore & Associates Inc.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.$ 1.22 Billion Growth Expected in Peripheral Vascular Stents Market | COVID-19 Impact Analysis in Q1 2021 | North America to Notice Maximum Growth | Technavio

Disclaimer: The following Press Release comes to you under a network of a strategic syndication partnership with PR Newswire. Prittle Prattle News takes no editorial responsibility for the same.

You may also like